Evidence map›Paper›PMID 41466926›Full record

ArticleCureus2025

Rare Lupus Exacerbation Shines Light on Provider Bias in a Patient With Possible Autoimmune Hepatitis.

Sarah Petelinsek, Kasey Stoutin, Patrick Hughes, Alexander E Kolomaya

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah PetelinsekSchool of Medicine, The University of Utah, Salt Lake City, USA.
Kasey StoutinDepartment of Internal Medicine, The University of Utah, Salt Lake City, USA.
Patrick HughesDepartment of Emergency Medicine, The University of Utah, Salt Lake City, USA.
Alexander E KolomayaDepartment of Internal Medicine, The University of Utah, Salt Lake City, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 42-year-old woman with a past medical history of alcohol use disorder, decompensated alcoholic cirrhosis, systemic lupus erythematosus (SLE), rheumatoid arthritis, and celiac disease presented to the emergency department (ED) for a four-day history of painful rash with worsening pruritus and acute kidney injury. After admission, dermatology, rheumatology, and nephrology teams were consulted, and a skin and renal biopsy were obtained, with results significant for lupus erythematosus tumidus (LET), lupus nephritis grade III (not active), and IgA nephritis, consistent with a systemic lupus erythematosus exacerbation. Despite the patient's history of autoimmune disease, she had previously never received a biopsy for autoimmune hepatitis (AIH) during her initial diagnosis of cirrhosis. During her admission, an autoimmune hepatitis panel was obtained with results suggestive of autoimmune hepatitis; however, a conclusive diagnosis requires a liver biopsy, which was not obtained inpatient. In patients with a strong history of alcohol use, anchoring on substance use as the sole driver of liver disease may be easy, but this case highlights the importance of keeping a wide differential and considering related illnesses, even in patients with pre-existing diagnoses.

Indexed as

alcohol-related liver diseasealcohol use disorder (aud)autoimmune hepatitis with cirrhosisdiagnostic biassytemic lupus erythematosustumid lupus erythematosusunconscious bias

Identifiers

PMID41466926
PMCPMC12744769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.